6CM
683 Capital Management Portfolio holdings
AUM
$986M
This Quarter Return
+7.22%
1 Year Return
+26.79%
3 Year Return
+135.86%
5 Year Return
+188.43%
10 Year Return
+750.26%
AUM
$1.02B
AUM Growth
+$1.02B
(+3.5%)
Cap. Flow
+$27.5M
Cap. Flow
% of AUM
2.71%
Top 10 Holdings %
Top 10 Hldgs %
35.51%
Holding
250
New
110
Increased
34
Reduced
29
Closed
29
Top Buys
| 1 |
Western Digital
WDC
|
$26.2M |
| 2 |
HES
Hess
HES
|
$14.3M |
| 3 |
GXO Logistics
GXO
|
$13.1M |
| 4 |
AMTM
Amentum Holdings, Inc.
AMTM
|
$8.94M |
| 5 |
ASML
ASML
|
$7.38M |
Top Sells
| 1 |
SharkNinja
SN
|
$19.6M |
| 2 |
BorgWarner
BWA
|
$16.7M |
| 3 |
TG Therapeutics
TGTX
|
$13.2M |
| 4 |
Hilton Grand Vacations
HGV
|
$10.7M |
| 5 |
IRS
IRSA Inversiones y Representaciones
IRS
|
$10M |
Sector Composition
| 1 | Healthcare | 31.96% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Financials | 9.47% |
| 4 | Industrials | 6.26% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares Silver Trust
SLV
$20.3B
| $1.97M | 0.12% |
75,000
+15,000
| +25% | +$395K |
|
77
Galapagos
GLPG
$2.05B
| $1.93M | 0.12% |
70,000
| – | – |
|
78
DHT Holdings
DHT
$1.93B
| $1.86M | 0.12% |
200,000
+100,000
| +100% | +$929K |
|
|
SVM
79
Silvercorp Metals
SVM
$1.11B
| $1.73M | 0.11% |
575,000
-25,000
| -4% | -$75K |
|
|
CRESW
80
Cresud S.A.C.I.F. y A. Warrant
CRESW
$49M
| $1.67M | 0.1% |
1,549,483
-866,537
| -36% | -$936K |
|
81
Aldeyra Therapeutics
ALDX
$350M
| $1.45M | 0.09% |
+290,000
| New | +$1.45M |
|
82
Ponce Financial Group
PDLB
$338M
| $1.38M | 0.09% |
106,137
| – | – |
|
83
Fractyl Health
GUTS
$69M
| $1.34M | 0.08% |
650,000
+25,000
| +4% | +$51.5K |
|
84
Invivyd
IVVD
$218M
| $1.33M | 0.08% |
3,000,000
| – | – |
|
85
Mersana Therapeutics
MRSN
$35.3M
| $1.29M | 0.08% |
900,000
+717,207
| +392% | +$1.03M |
|
86
Shattuck Labs
STTK
$57M
| $1.27M | 0.08% |
+1,050,000
| New | +$1.27M |
|
87
FibroGen
FGEN
$47.8M
| $1.13M | 0.07% |
2,138,402
| – | – |
|
88
Lennar Class A
LEN
$34.8B
| $1.02M | 0.06% |
+7,500
| New | +$1.02M |
|
89
Ingevity
NGVT
$2.11B
| $1.02M | 0.06% |
25,000
| – | – |
|
90
Eton Pharmaceutcials
ETON
$462M
| $919K | 0.06% |
+69,000
| New | +$919K |
|
91
Hyliion Holdings
HYLN
$288M
| $914K | 0.06% |
+350,000
| New | +$914K |
|
|
ATYR
92
aTyr Pharma
ATYR
$563M
| $898K | 0.06% |
+248,000
| New | +$898K |
|
93
Emergent Biosolutions
EBS
$427M
| $886K | 0.05% |
+92,691
| New | +$886K |
|
94
LifeVantage
LFVN
$170M
| $868K | 0.05% |
+49,500
| New | +$868K |
|
95
ClearPoint Neuro
CLPT
$289M
| $836K | 0.05% |
+54,387
| New | +$836K |
|
|
AFMD
96
DELISTED
Affimed
AFMD
| $779K | 0.05% |
654,600
+4,600
| +0.7% | +$5.47K |
|
97
Personalis
PSNL
$427M
| $775K | 0.05% |
+134,000
| New | +$775K |
|
98
Atomera
ATOM
$98.9M
| $770K | 0.05% |
+66,362
| New | +$770K |
|
99
Kingstone Companies
KINS
$190M
| $768K | 0.05% |
+50,540
| New | +$768K |
|
100
Travelzoo
TZOO
$105M
| $751K | 0.05% |
+37,661
| New | +$751K |
|